Matches in Nanopublications for { ?s ?p "[Glycosphingolipids are known to play an important role in organ function at least in part from inherited lipid storage diseases such as Anderson-Fabry disease (Fabry's disease; FD) that results from a mutation in alpha-galactosidase a (α-GLA or α-Gal A), the enzyme responsible for catalyzing the removal of terminal galactose residues from glycosphingolipids.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP813360.RAeWp1gmYaI4GiMD9lBrkmUT3WpJhJuEfFPKMKIE1f1Ew130_assertion description "[Glycosphingolipids are known to play an important role in organ function at least in part from inherited lipid storage diseases such as Anderson-Fabry disease (Fabry's disease; FD) that results from a mutation in alpha-galactosidase a (α-GLA or α-Gal A), the enzyme responsible for catalyzing the removal of terminal galactose residues from glycosphingolipids.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP813360.RAeWp1gmYaI4GiMD9lBrkmUT3WpJhJuEfFPKMKIE1f1Ew130_provenance.
- NP923092.RA0zn-cVY5aNnOixXIruBTS-Uq9VO9799DRNP788Yy--U130_assertion description "[Glycosphingolipids are known to play an important role in organ function at least in part from inherited lipid storage diseases such as Anderson-Fabry disease (Fabry's disease; FD) that results from a mutation in alpha-galactosidase a (α-GLA or α-Gal A), the enzyme responsible for catalyzing the removal of terminal galactose residues from glycosphingolipids.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923092.RA0zn-cVY5aNnOixXIruBTS-Uq9VO9799DRNP788Yy--U130_provenance.
- NP923091.RAMHvK7RRs2Me8WGH218gTJJrsGgXnduhqw4oO_w0-3fE130_assertion description "[Glycosphingolipids are known to play an important role in organ function at least in part from inherited lipid storage diseases such as Anderson-Fabry disease (Fabry's disease; FD) that results from a mutation in alpha-galactosidase a (α-GLA or α-Gal A), the enzyme responsible for catalyzing the removal of terminal galactose residues from glycosphingolipids.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923091.RAMHvK7RRs2Me8WGH218gTJJrsGgXnduhqw4oO_w0-3fE130_provenance.